Pharma Blister Packaging Industry is Likely to offer an Absolute Dollar Opportunity of US$ 8 Billion by 2032

The market for pharmaceutical blister packaging is anticipated to reach US$ 10.5 Bn in 2022 and US$ 19 Bn by 2032, at a 6% CAGR between 2022 and 2032. The need for pharmaceutical blister packaging is expected to expand somewhat, according to Fact.MR, a source of market research and competitive information.

The pharmaceutical packaging business is anticipated to hold a market share of roughly 4% of the estimated $300 billion packaging sector. Additionally, the blister packaging industry is anticipated to reach US$ 15 billion, with the pharmaceutical blister packaging market expected to hold 70% of the market share.

Download Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=452?AS 

Key Highlights 

In 2017, around 738 thousand tons of carded blister packs have been sold in the global pharmaceuticals industry. However, the report estimates that the demand for carded packs will dwindle in the global pharma blisters packaging market towards the end of the forecast period. Meanwhile, clamshell blister packs will represent the fastest-selling product in the global pharma blisters packaging market, reflecting a volume CAGR of 6% over the forecast period.

Through 2026, thermoforming technology will be predominantly used in the production of blister packages for pharmaceutical products. The report estimates that by the end of 2026, nearly 1,290 thousand tons of thermoformed blisters will be sold across the global pharma blisters packaging market.

Cold forming technology will also gain traction in the global pharma blisters packaging market, and will register a robust volume CAGR of 6.5% during the forecast period.

By the end of 2026, high-density polyethylene (HDPE) and aluminum will represent the two widely-used materials for pharma blisters packaging. Nevertheless, polyethylene terephthalate will register highest use as a key materials for manufacturing blister packs.

 In 2018 and beyond, tablets will be the largest application in the global pharma blisters packaging market. By the end of 2026, more than 1,000 thousand tons of pharma blisters packaging products will be used in tablets applications across the globe. The report also estimates that throughout the forecast period, over 50% of the global pharma blisters packaging market volumes will be used in tablets applications.

In terms of regions, North America is pegged to represent the largest market for pharma blisters packaging, accounting for the fastest expansion at a volume CAGR of 6.5% over the forecast period. The report also estimates that Europe's pharma blisters packaging market will expand robustly, accounting for approximately one-fourth share of global market volumes over the forecast period.

Market Frontrunners

ACG Pharmapack Pvt. Ltd.
Amcor Limited.
Honeywell International, Inc.
Klöckner Pentaplast Group
The Dow Company

Market Structure

Key Segments Covered

• Product Type
o Clamshell
o Carded

• Technology Type
o Cold Forming
o Thermoforming

• Material Type

o Polyethylene Terephthalate (PET, PETE, PETG or polyester)
o High Density Polyethylene (HDPE)
o Polyvinyl Chloride (PVC)
o Low Density Polyethylene (LDPE)
o Aluminum
o Paper & Paper Board

• Application
o Tablets
o Capsules
o Powders
o Medical Devices

Queries addressed in the Pharma blister packaging report:

Why are the Pharma blister packaging players targeting region for increased product sales?
What patented technologies are the players utilizing in the global Pharma blister packaging?
Which regions are displaying the fastest growth in the Pharma blister packaging?
What are the underlying micro- macroeconomic factors affecting the global Pharma blister packaging?

Get Customization on this Report for Specific Research Solutions:https://www.factmr.com/connectus/sample?flag=RC&rep_id=452?AS

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

About Fact.MR;

Fact.MR research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.

This release was published on openPR.